A significant discovery in cancer study is emerging with the use of nanobodies to re-engage mutated p53. This essential cancer inhibitor protein is frequently disabled in several kinds of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research